Objective: To evaluate the antihyperlipidemic potential of the Ethanolic Extract of Root tubers of Asparagus gonoclados (EERAG) in cholesterol diet induced hyperlipidemic rats. Methods: Wistar albino rats were randomly divided into five groups of six each. Group-I served as normal control. Groups II to V were given 5% cholesterol diet for 3 months to induce hyperlipidaemia, and for last 28 days were administered either: 0.5ml water/saline for Group- I; cholesterol diet (5%) for Group-II; Standard drug Rosuvastatin (20mg/kg body weight) for Group-III; A .gonoclados extract at 250 mg/kg bodyweight for Group-IV and 500mg/kg body weight for Group-V. The effects of EERAG on serum lipid profile, Body Weight and antioxidant enzymes (Superoxide Di...
Background: There is always a need for developing novel drugs with higher efficacy and fewer side ef...
Objective: The aim of the present study was to investigate the effect of antihyperlipidemic activity...
Introduction: Hyperlipidemia is a modifiable risk factor of an important killer disease “cardiovascu...
Objective: To evaluate the antihyperlipidemic potential of the Ethanolic Extract of Root tubers of A...
Background: Atherosclerosis is associated with hyperlipidemia which is a major risk factor for coron...
The cultivated species of the wild autochthonous Asparagus officinalis in Andalusia in Spain is common...
We have previously shown that the Andalusian-cultivated Asparagus officinalis L. “triguero” variety ...
Objectives: High lipids and carbohydrate have been seriously implicated to cardiovascular problems,...
Background: Hyperlipidaemia is a common disease in middle-aged and elderly people. It has received a...
13 Páginas.-- 2 Figuras.-- 2 TablasWe have previously shown that the Andalusian-cultivated Asparagus...
OBJECTIVE: To study the efficacy of Asparagus racemosus in reducing the cholesterol levels and...
Objective: The present study is an attempt to investigate its anti-hyperlipidemic activity of methan...
Objective: The objective of this research article is to develop and evaluate polyherbal preparation ...
We have previously shown that the Andalusian-cultivated Asparagus officinalis L. “triguero” variety ...
Background: Hypercholesterolemia is a condition characterised with high level of cholesterol in the ...
Background: There is always a need for developing novel drugs with higher efficacy and fewer side ef...
Objective: The aim of the present study was to investigate the effect of antihyperlipidemic activity...
Introduction: Hyperlipidemia is a modifiable risk factor of an important killer disease “cardiovascu...
Objective: To evaluate the antihyperlipidemic potential of the Ethanolic Extract of Root tubers of A...
Background: Atherosclerosis is associated with hyperlipidemia which is a major risk factor for coron...
The cultivated species of the wild autochthonous Asparagus officinalis in Andalusia in Spain is common...
We have previously shown that the Andalusian-cultivated Asparagus officinalis L. “triguero” variety ...
Objectives: High lipids and carbohydrate have been seriously implicated to cardiovascular problems,...
Background: Hyperlipidaemia is a common disease in middle-aged and elderly people. It has received a...
13 Páginas.-- 2 Figuras.-- 2 TablasWe have previously shown that the Andalusian-cultivated Asparagus...
OBJECTIVE: To study the efficacy of Asparagus racemosus in reducing the cholesterol levels and...
Objective: The present study is an attempt to investigate its anti-hyperlipidemic activity of methan...
Objective: The objective of this research article is to develop and evaluate polyherbal preparation ...
We have previously shown that the Andalusian-cultivated Asparagus officinalis L. “triguero” variety ...
Background: Hypercholesterolemia is a condition characterised with high level of cholesterol in the ...
Background: There is always a need for developing novel drugs with higher efficacy and fewer side ef...
Objective: The aim of the present study was to investigate the effect of antihyperlipidemic activity...
Introduction: Hyperlipidemia is a modifiable risk factor of an important killer disease “cardiovascu...